Identification of a serum biomarker signature associated with metastatic prostate cancer is a research paper published in PROTEOMICS - CLINICAL APPLICATIONS (2021). On theSindex it has a DataRank of 0.510. It has been cited 4 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.269
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
Cancerfonden
Grant: CAN 2017/559
Vinnova
Grant: UDI 2016‐00462
National Cancer Institute
Grant: SPORE grant in Prostate Cancer [P50‐CA92629]
National Cancer Institute
Grant: Support Grant to MSKCC [P30 CA008748]
Vetenskapsrådet
Grant: (VR‐MH project no. 2016‐02974)
National Institute for Health Research (NIHR)
Grant: 96/20/06
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: P50 CA092629
National Institutes of Health
Grant: 5P50CA092629-10
RATIONAL DESIGN OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN DNA VACCINES
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
Swedish Governmental Agency for Innovation Systems
Grant: unidentified
unidentified
National Institute for Health Research (NIHR)
Sidney Kimmel Center for Prostate and Urologic Cancers
FWCI
0.52
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals